tradingkey.logo
tradingkey.logo
Search

DaVita Inc

DVA
Add to Watchlist
210.975USD
+1.295+0.62%
Close 06/23, 16:00ETQuotes delayed by 15 min
13.96BMarket Cap
19.29P/E TTM

More Details of DaVita Inc Company

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.

DaVita Inc Info

Ticker SymbolDVA
Company nameDaVita Inc
IPO dateOct 31, 1995
CEORodriguez (Javier J)
Number of employees76000
Security typeOrdinary Share
Fiscal year-endOct 31
Address2000 16th St
CityDENVER
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code80202-5117
Phone13105362668
Websitehttps://www.davita.com/
Ticker SymbolDVA
IPO dateOct 31, 1995
CEORodriguez (Javier J)

Company Executives of DaVita Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
775.74K
-8.95%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
110.08K
-46.76%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
90.89K
-16.95%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.95K
+0.93%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
26.55K
-77.32%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%
Mr. James O. Hearty
Mr. James O. Hearty
Chief Compliance Officer
Chief Compliance Officer
15.53K
-101.43%
Ms. Barbara J. Desoer
Ms. Barbara J. Desoer
Independent Director
Independent Director
14.02K
+1.78%
Ms. Phyllis R. Yale
Ms. Phyllis R. Yale
Independent Director
Independent Director
9.53K
-50.27%
Dr. Gregory J. Moore, M.D., Ph.D.
Dr. Gregory J. Moore, M.D., Ph.D.
Independent Director
Independent Director
7.81K
+3.20%
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Javier J. Rodriguez
Mr. Javier J. Rodriguez
Chief Executive Officer, Director
Chief Executive Officer, Director
775.74K
-8.95%
Mr. Joel Ackerman
Mr. Joel Ackerman
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
110.08K
-46.76%
Ms. Kathleen Alyce Waters
Ms. Kathleen Alyce Waters
Chief Legal and Public Affairs Officer
Chief Legal and Public Affairs Officer
90.89K
-16.95%
Ms. Pamela M. Arway
Ms. Pamela M. Arway
Independent Chair of the Board
Independent Chair of the Board
26.95K
+0.93%
Mr. David P. Maughan
Mr. David P. Maughan
Chief Operating Officer - Davita Kidney Care
Chief Operating Officer - Davita Kidney Care
26.55K
-77.32%
Mr. Christopher Michael (Chris) Berry
Mr. Christopher Michael (Chris) Berry
Chief Accounting Officer
Chief Accounting Officer
19.61K
+18.61%

FAQs

Who are the top five shareholders of DaVita Inc?

The top five shareholders of DaVita Inc are: Mr. Javier J. Rodriguez

How many institutions hold shares of DaVita Inc (DVA)?

As of 2026Q1, 1310 institutions hold shares of DaVita Inc, with a combined market value of approximately 36.02M, accounting for 56.10% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -3261619.00.

What is the biggest source of revenue for DaVita Inc?

In 2026Q1, the Patient service - Medicare and Medicare Advantage business generated the highest revenue for DaVita Inc, amounting to 6.74B and accounting for 49.41% of total revenue.
KeyAI